drugset / Trial / NCT00145249

Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis

NCT00145249

RandomizedParallel-groupOpen-labelTreatment

Summary

This study will examine the effectiveness and safety of a combination treatment for cryptococcal meningitis, a fungal infection common in persons with acquired immune deficiency syndrome (AIDS) in the developing world. The standard initial treatment includes two medications: amphotericin B for 2 weeks followed by 8 weeks of fluconazole. This study will look at whether study participants recover more quickly and have fewer side effects if they are given both drugs at the same time for 2 weeks followed by 8 weeks of fluconazole as compared to the standard treatment. Participants will be followed for approximately 6 months from the time they are enrolled into the study.

Timeline

Start
2005-05
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Amphotericin B Unknown 0.7 mg/kg Intravenous
Subject Fluconazole Small molecule 200 mg/kg Oral
Subject Fluconazole Small molecule 400 mg Oral
Subject Fluconazole Small molecule 400 mg/kg Oral
Subject Fluconazole Small molecule 800 mg Oral